Lactylated APP in the endosomes inhibits its binding to BACE1 and subsequent cleavage but, conversely, promotes the protein interaction between APP and CD2AP, which may accelerate the endosomal-lysosomal degradation system and lead to reduced Aβ deposition and improved memory in AD model mice (Figure 9). This evidence concerns the gene APP and Alzheimer disease.